Exploitation of polyphenols and proteins using nanoencapsulation for anti-viral and brain boosting properties - Evoking a synergistic strategy to combat COVID-19 pandemic. - OpacWWW

Szczegóły
Abstrakt

Tytuł:: Exploitation of polyphenols and proteins using nanoencapsulation for anti-viral and brain boosting properties - Evoking a synergistic strategy to combat COVID-19 pandemic.
Autorzy:: Noor N; Laboratory of Functional Food and Nutraceuticals, Department of Food Science and Technology, University of Kashmir, Srinagar 190006, India.
Gani A; Laboratory of Functional Food and Nutraceuticals, Department of Food Science and Technology, University of Kashmir, Srinagar 190006, India; Department of Food Science, Rutgers University, 65 Dudley Road, New Brunswick, NJ 08901, United States. Electronic address: .
Gani A; Laboratory of Functional Food and Nutraceuticals, Department of Food Science and Technology, University of Kashmir, Srinagar 190006, India.
Shah A; Laboratory of Functional Food and Nutraceuticals, Department of Food Science and Technology, University of Kashmir, Srinagar 190006, India.
Ashraf ZU; Laboratory of Functional Food and Nutraceuticals, Department of Food Science and Technology, University of Kashmir, Srinagar 190006, India.
Źródło:: International journal of biological macromolecules [Int J Biol Macromol] 2021 Jun 01; Vol. 180, pp. 375-384. Date of Electronic Publication: 2021 Mar 11.
Typ publikacji:: Journal Article; Review
Język:: English
Imprint Name(s):: Publication: Amsterdam : Elsevier
Original Publication: Guildford, Eng., IPC Science and Technology Press.
MeSH Terms:: Antiviral Agents*/chemistry
Antiviral Agents*/therapeutic use
COVID-19*/epidemiology
Mental Health*
Nanocapsules*/chemistry
Nanocapsules*/therapeutic use
Pandemics*
Polyphenols*/chemistry
Polyphenols*/therapeutic use
SARS-CoV-2*
Humans
References:: Int Immunopharmacol. 2021 Feb;91:107245. (PMID: 33348292)
Phytomedicine. 2009 Jun;16(6-7):594-600. (PMID: 19195858)
J Nutr Gerontol Geriatr. 2012;31(3):176-89. (PMID: 22888837)
Analyst. 2008 May;133(5):626-34. (PMID: 18427684)
Colloids Surf B Biointerfaces. 2018 Feb 1;162:60-68. (PMID: 29149729)
Int Arch Allergy Immunol. 1992;97(1):17-24. (PMID: 1582693)
Biomacromolecules. 2006 May;7(5):1623-9. (PMID: 16677047)
Antimicrob Agents Chemother. 2016 Aug 22;60(9):5182-8. (PMID: 27297486)
Lancet. 2020 Feb 22;395(10224):565-574. (PMID: 32007145)
J Biomol Struct Dyn. 2022 Mar;40(5):2113-2120. (PMID: 33094705)
Free Radic Biol Med. 2002 Feb 15;32(4):314-8. (PMID: 11841921)
Nat Nanotechnol. 2007 Dec;2(12):751-60. (PMID: 18654426)
Mol Nutr Food Res. 2005 Dec;49(12):1143-50. (PMID: 16252309)
Indian J Pharmacol. 2020 Jan-Feb;52(1):56-65. (PMID: 32201449)
Chem Res Toxicol. 2007 Apr;20(4):583-5. (PMID: 17362033)
Lancet. 2020 Feb 15;395(10223):470-473. (PMID: 31986257)
Food Res Int. 2015 Aug;74:97-105. (PMID: 28412008)
Matter. 2020 Sep 2;3(3):598-601. (PMID: 32905308)
Neural Regen Res. 2015 Jul;10(7):1113-9. (PMID: 26330835)
Int J Pharm. 2013 Sep 10;453(2):630-40. (PMID: 23727139)
Biochem Biophys Res Commun. 2018 Jun 12;500(4):860-865. (PMID: 29698680)
Brain Res. 2016 Nov 15;1651:17-26. (PMID: 27639810)
Nanomedicine. 2010 Feb;6(1):153-60. (PMID: 19616123)
Clin Nutr. 2008 Feb;27(1):5-15. (PMID: 18061312)
J Biochem. 2008 Jun;143(6):833-9. (PMID: 18344541)
Parasitol Res. 2012 Feb;110(2):593-8. (PMID: 21739309)
Food Chem Toxicol. 2019 Dec;134:110827. (PMID: 31542433)
Nanoscale. 2016 Feb 7;8(5):3040-8. (PMID: 26781043)
J Ethnopharmacol. 2010 Feb 3;127(2):280-5. (PMID: 19914366)
EMBO Rep. 2004 Apr;5(4):418-22. (PMID: 15031715)
Foodborne Pathog Dis. 2011 Nov;8(11):1177-83. (PMID: 21777065)
Front Nutr. 2017 May 16;4:19. (PMID: 28560212)
Behav Pharmacol. 2012 Aug;23(4):339-47. (PMID: 22785384)
Acc Chem Res. 2013 Mar 19;46(3):792-801. (PMID: 23387478)
J Enzyme Inhib Med Chem. 2017 Dec;32(1):504-515. (PMID: 28112000)
Acta Pharm Sin B. 2020 Jul;10(7):1163-1174. (PMID: 32834947)
ACS Appl Mater Interfaces. 2012 Sep 26;4(9):5016-21. (PMID: 22834763)
Antiviral Res. 2007 Sep;75(3):179-87. (PMID: 17428553)
Int J Pharm. 2011 May 30;410(1-2):111-3. (PMID: 21419204)
Pharmacol Res. 2019 Jun;144:245-256. (PMID: 31005617)
Colloids Surf B Biointerfaces. 2013 Mar 1;103:182-8. (PMID: 23201736)
Theranostics. 2020 May 1;10(13):5932-5942. (PMID: 32483428)
Sci Rep. 2019 May 3;9(1):6876. (PMID: 31053743)
Appetite. 2016 May 1;100:126-32. (PMID: 26873453)
Sci Rep. 2017 Mar 31;7(1):519. (PMID: 28364126)
Eur J Pharmacol. 2021 Jan 15;891:173759. (PMID: 33249077)
J Virol. 2005 Dec;79(23):14614-21. (PMID: 16282461)
Pharmacol Biochem Behav. 2006 Sep;85(1):160-9. (PMID: 16950503)
Maturitas. 2010 Jun;66(2):163-71. (PMID: 20181448)
Int J Biochem Cell Biol. 2008;40(12):2802-14. (PMID: 18598778)
J Nanobiotechnology. 2013 Sep 23;11:32. (PMID: 24059692)
Chem Commun (Camb). 2003 Dec 7;(23):2920-1. (PMID: 14680241)
Biochem Pharmacol. 2010 Feb 1;79(3):330-8. (PMID: 19735646)
Mater Sci Eng C Mater Biol Appl. 2018 Aug 1;89:274-282. (PMID: 29752099)
J Agric Food Chem. 2012 Mar 14;60(10):2712-20. (PMID: 22352467)
Neurochem Int. 2013 May;62(6):836-42. (PMID: 23454192)
Neurology. 2013 Sep 3;81(10):904-9. (PMID: 23925758)
Hepatology. 2009 Dec;50(6):1756-64. (PMID: 19839005)
Mol Nutr Food Res. 2007 Jun;51(6):702-13. (PMID: 17533653)
Hum Gene Ther. 1997 Mar 1;8(4):431-8. (PMID: 9054518)
J Funct Foods. 2009 Jan 1;1(1):74-87. (PMID: 20046888)
Neurochem Res. 2018 Sep;43(9):1705-1713. (PMID: 29943083)
ACS Appl Mater Interfaces. 2019 Nov 20;11(46):42964-42974. (PMID: 31633330)
Front Cell Neurosci. 2013 Dec 26;7:281. (PMID: 24421757)
Int J Biol Macromol. 2018 May;111:534-541. (PMID: 29289668)
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2445-53. (PMID: 23810791)
J Biol Chem. 2003 Sep 12;278(37):34783-93. (PMID: 12826665)
Arch Virol. 2015 Feb;160(2):399-407. (PMID: 25491197)
ACS Appl Nano Mater. 2020 May 22;3(5):4913. (PMID: 35286056)
PLoS One. 2015 Jun 29;10(6):e0131758. (PMID: 26121135)
Cell Mol Life Sci. 2007 Aug;64(16):2153-69. (PMID: 17514358)
Oxid Med Cell Longev. 2013;2013:891748. (PMID: 23840922)
Sci Rep. 2018 Nov 12;8(1):16687. (PMID: 30420770)
J Control Release. 2016 Mar 10;225:1-30. (PMID: 26778694)
Int J Antimicrob Agents. 2020 Jun;55(6):105971. (PMID: 32283177)
Prog Clin Biol Res. 1986;213:521-36. (PMID: 3012583)
Colloids Surf B Biointerfaces. 2018 Oct 1;170:322-329. (PMID: 29936385)
J Cell Biochem. 2013 Oct;114(10):2209-20. (PMID: 23554028)
Eur J Pharmacol. 2019 Sep 15;859:172538. (PMID: 31310752)
Mil Med Res. 2020 Feb 6;7(1):4. (PMID: 32029004)
Virology. 2005 May 10;335(2):177-84. (PMID: 15840517)
Biotechnol Lett. 2012 May;34(5):831-8. (PMID: 22350287)
Curr Drug Deliv. 2015;12(1):86-97. (PMID: 25233122)
Proc Natl Acad Sci U S A. 2020 Jan 28;117(4):2122-2132. (PMID: 31932446)
Nano Today. 2021 Feb;36:101051. (PMID: 33519949)
Antioxid Redox Signal. 2001 Dec;3(6):1009-21. (PMID: 11813977)
Bioconjug Chem. 2010 Mar 17;21(3):521-30. (PMID: 20128624)
Eur J Pharm Biopharm. 2010 Jun;75(2):179-85. (PMID: 20144711)
Oxid Med Cell Longev. 2012;2012:805762. (PMID: 22829964)
Int J Pharm. 2011 Jan 17;403(1-2):285-91. (PMID: 21035530)
Am J Clin Nutr. 2015 May;101(5):914-21. (PMID: 25934864)
J Mass Spectrom. 2003 Jan;38(1):35-42. (PMID: 12526004)
Pharmacol Ther. 2006 Sep;111(3):877-92. (PMID: 16540173)
Food Res Int. 2015 Oct;76(Pt 3):626-636. (PMID: 28455046)
Cell. 2015 Oct 22;163(3):746-58. (PMID: 26496612)
J Neurotrauma. 2000 Dec;17(12):1219-31. (PMID: 11186234)
Arch Pharm Res. 2000 Feb;23(1):1-16. (PMID: 10728649)
Carbohydr Polym. 2018 Aug 1;193:99-107. (PMID: 29773403)
ACS Appl Mater Interfaces. 2018 Feb 7;10(5):4369-4378. (PMID: 29337529)
Plant Physiol. 1995 Oct;109(2):347-52. (PMID: 7480335)
Food Environ Virol. 2009 Dec;1(3-4):123-128. (PMID: 20234879)
Mini Rev Med Chem. 2010 Jun;10(6):550-67. (PMID: 20370701)
ACS Appl Mater Interfaces. 2013 May 22;5(10):4173-80. (PMID: 23668627)
Lancet. 2019 Jun 8;393(10188):2312-2321. (PMID: 31030981)
Toxicon. 2012 Jan;59(1):12-6. (PMID: 22005297)
Physiol Behav. 2017 Mar 15;171:69-78. (PMID: 28069457)
Asian J Psychiatr. 2020 Jun;51:102083. (PMID: 32283510)
Int J Pharm. 2010 Nov 15;400(1-2):211-20. (PMID: 20813175)
J Med Virol. 2020 May;92(5):479-490. (PMID: 32052466)
Acta Biomater. 2010 Apr;6(4):1258-68. (PMID: 19683605)
Planta. 2000 Sep;211(4):546-54. (PMID: 11030554)
J Neuropathol Exp Neurol. 2011 Aug;70(8):653-61. (PMID: 21760540)
J Nutr. 2008 Sep;138(9):1671-6. (PMID: 18716168)
Drug Discov Today. 2020 Sep;25(9):1556-1558. (PMID: 32592866)
Contributed Indexing:: Keywords: Caffeine; Cocoa flavonoids; Lectins; Nanoencapsulation; Quercetin
Substance Nomenclature:: 0 (Antiviral Agents)
0 (Nanocapsules)
0 (Polyphenols)
Entry Date(s):: Date Created: 20210315 Date Completed: 20210517 Latest Revision: 20221217
Update Code:: 20240104
PubMed Central ID:: PMC7946821
DOI:: 10.1016/j.ijbiomac.2021.03.028
PMID:: 33716131
: Czasopismo naukowe

Full Text Finder

The world is currently under the threat of COVID pandemic and has focused every dimension of research in finding a cure to this novel disease. In this current situation, people are facing mental stress, agony, fear, depression and other associated symptoms which are taking a toll on their overall mental health. Nanoencapsulation of certain brain boosting polyphenols including quercetin, caffeine, cocoa flavanols and proteins like lectins can become new area of interest in the present scenario. Besides the brain boosting benefits, we have also highlighted the anti- viral activities of these compounds which we assume can play a possible role in combating COVID-19 given to their previous history of action against certain viruses. This review outlines the nanoencapsulation approaches of such synergistic compounds as a novel strategy to take the ongoing research a step ahead and also provides a new insight in bringing the role of nanotechnology in addressing the issues related to COVID pandemic.
Competing Interests: Declaration of competing interest There are no conflicts to declare.
(Copyright © 2021 Elsevier B.V. All rights reserved.)

Informacja

Exploitation of polyphenols and proteins using nanoencapsulation for anti-viral and brain boosting properties - Evoking a synergistic strategy to combat COVID-19 pandemic.